Express Scripts to Partner With Imprimis Pharmaceuticals to Offer Alternative to Daraprim for $1.00/Pill
December 01, 2015 at 04:11 AM EST
Express Scripts (NASDAQ: ESRX) today announced it will partner with Imprimis Pharmaceuticals (NASDAQ: IMMY) to drive access to a ...
